- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Lupus
The Rheumatology Network lupus clinical focus page provides information on the latest lupus news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for systemic lupus erythematosus drugs.
Anne Winkler, MD: Targeting Lupus Nephritis
May 12, 2022
Anne Winkler, MD, discusses her upcoming CCR East presentation, “Targeting Lupus Nephritis.”
Lupus Nephritis: TULIP-LN Hints at a Blossoming Role for Anifrolumab
May 10, 2022
In the double blinded study, patients were randomized to receive anifrolumab (300mg monthly), an intensified regimen of 3 x 900mg doses followed by 300mg monthly, or standard of care therapy with mycophenolate mofetil and oral glucocorticoids.
From Living BLISSfully to BEATing Lupus: Future Considerations for Biologic Therapy in SLE
May 09, 2022
After years of frustration and failure, trials of targeted biologic therapy in systemic lupus erythematosus are beginning to show success. New drugs, including anifrolumab (Saphnelo) and belimumab (Benlysta), are paving the way for an exciting new era. However, this raises new questions as to how these novel therapeutics will be incorporated into future clinical practice.
Cognitive Performance Significantly Lower in Patients With SLE
May 05, 2022
The cross-sectional analysis determined cognitive performance of patients with systemic lupus erythematosus was significantly lower when compared with controls in both motor speed and psychomotor speed domains.
Manuel Francisco Ugarte-Gil, MD, MSc: Severe Flares and Poorer Quality of Life in Patients With SLE
April 25, 2022
Manuel Francisco Ugarte-Gil, MD, MSc, explains the impact that severe flares have on health-related quality of life for patients with systemic lupus erythematosus.
Shanthini Kasturi, MD, MS: Patient-Reported Outcome Measures to Enhance SLE Treatment
April 22, 2022
Shanthini Kasturi, MD, MS, discusses the importance of patient-reported outcome measures to optimize the care of patients with systemic lupus erythematosus.
TeleLupus in the Context of COVID-19: Is There a Long-Term Role for Remote Consultation in How We Manage Lupus Patients?
April 21, 2022
Telemedicine is an evolving and helpful tool in how rheumatologists manage their outpatient cohort. However, careful distinction of who can continue to be managed remotely is crucial.
Joyce Chang, MD, MSCE: Racial Disparities in Children With Systemic Lupus Erythematosus
April 21, 2022
Joyce C. Chang MD, MSCE, discusses the racial disparities in renal outcomes for hospitalized children with systemic lupus erythematosus.
Belimumab Shows Favorable Long-Term Disease Control in Patients With SLE
April 20, 2022
Until now, there has been limited information on the long-term safety and efficacy of belimumab in Chinese patients with systemic lupus erythematosus.
Severe Flares in Patients With SLE Linked to Poorer Quality of Life
April 19, 2022
Disease flares in systemic lupus erythematosus are associated with damage. However, the impact of flares on health-related quality of life have not been analyzed.